Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20377Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Katsouras, C. S. | en |
| dc.contributor.author | Tsironis, L. D. | en |
| dc.contributor.author | Elisaf, M. S. | en |
| dc.contributor.author | Goodevenos, J. A. | en |
| dc.contributor.author | Michalis, L. K. | en |
| dc.contributor.author | Tselepis, A. D. | en |
| dc.date.accessioned | 2015-11-24T19:06:47Z | - |
| dc.date.available | 2015-11-24T19:06:47Z | - |
| dc.identifier.issn | 1744-8298 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20377 | - |
| dc.rights | Default Licence | - |
| dc.title | Lipoprotein(a) as a cardiovascular risk factor | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | 10.2217/14796678.1.4.509 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19804152 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2005 | - |
| heal.abstract | Evidence for the role of lipoprotein(a) (Lp[a]) in atherosclerosis and thrombosis has considerably increased over the past few years. Therefore, Lp(a) is currently classified as an emerging lipid risk factor for cardiovascular disease. High Lp(a) plasma levels carried in particles with small-sized apolipoprotein(a) isoforms are associated with preclinical vascular changes, cardiovascular disease and the mode of presentation of coronary artery disease (acute coronary syndromes). However, randomized clinical trials with an emphasis on agents that specifically lower plasma Lp(a) do not exist. At present, screening for increases in Lp(a) in the general population is not recommended. The measurement of Lp(a) may be of value in individuals with an increased risk of cardiovascular disease, particularly in patients with high low-density lipoprotein cholesterol plasma levels, since a high Lp(a) concentration in such subjects further increases the risk of coronary heart disease. | en |
| heal.journalName | Future Cardiol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
